Tactile Systems Technology Inc
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Current Price
$24.17
+0.50%GoodMoat Value
$55.36
129.0% undervaluedTactile Systems Technology Inc (TCMD) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Tactile Systems Technology Inc's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $343.52M. Gross profit (TTM) is $262.41M. EBITDA is $41.71M. Earnings per share (EPS) is $0.82. The P/E ratio is 26.59. Market capitalization is $539.66M.
Free cash flow (FCF) is $40.43M. EPS growth CAGR is 9.67%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Tactile Systems Technology Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
